Market Research Blog

Hospitals to hold largest share in Ultrasound Systems Market with highest demand for application in Radiology

Hospitals shift toward more value-oriented products, they need to operate more efficiently and productively. Similarly, a quality shift has occurred with patients, who more proactively involved in their care. Trends from the shift to value-based care include data integration and population health management. An influx of data combined with advancements in imaging helps leverage these data to not only bring further value but also apply it to broader populations. Along with the clearer and high definition pictures that are a part of ultrasound systems, there has also been an introduction to the portable machines. These are the more handy and easy to move form of ultrasound systems that have come into existence not long ago. Although the developed nations are already familiar with the technology, the market may find a higher prospects of growth in the developing regions. The market analysis has shown that hospitals hold the highest market share in the Global Ultrasound Systems Market, however diagnostics imaging and surgical centers are expected to raise a higher demand for the systems in the coming years. In terms of application the market is also dominated by Radiology as the key application area for ultrasound systems and is expected to continue growing further at a CAGR of 6.3% during the forecast period, as analyzed by FMI.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6695

Favourable Government Policies to Benefit Start-up Companies and Independent diagnostic centers

As a move to encourage start-up companies, government of various regions like Asia Pacific and MEA have bolstered the initiatives to support the new start-ups who are entering the healthcare and medical device industry. It includes exemption of taxes for the first three years, subsidizing patent protection cost etc. The move is intended to boost the overall market for medical devices. Specifically the medical imaging market has also taken an independent position in the global market. With the betterment in services and advanced facilities related to ultrasound or any other imaging techniques, the global market is expected to witness a higher volume of independent imaging centers. The companies have also independently introduced handy and user-friendly devices in the market. GE, Philips, Samsung, Fukuda, Mindray, Hitachi, Toshiba, and Siemens, all these companies offer their own particular models.

High prices and reimbursement regulations may hinder the overall growth of Global Ultrasound Systems Market

High end ultrasound systems can cost a fortune for the healthcare providers. Especially the ones that are equipped with new and advanced technology, are higher in price and cannot be affordable for small scale hospitals or diagnostic centers.

The top end machines usually cost US$ 55,000 to US$ 100,000 and governments of many regions do not provide enough grants for it. This has made many regions like Asia Pacific and Latin America more reluctant to afford it. This is primarily attributed to lack of awareness among patients about these systems, which negatively affects its uptake.

The market is also facing an impact of FDA regulations and reimbursement scenario. The regulations for ultrasound devices are quite stringent owing to the possible harms these devices could cause to the human body. It is required to be handled by equipment expert, however there is a serious lack of skilled labor in the industry, which may lower the adoption rate of advanced equipment.

The players in the market are increasingly focusing on raising their market penetration through exploration of the untapped markets. In order to increase its market penetration, the company is focusing on enhancement of its products by introducing new technologies and upgrading its existing products and also simultaneously focusing on strategic alliances for sale and promotion of its products globally. Manufacturers are basically focusing on upscaling the production of automated gait trainer.

The proliferating acquisition activities and contractual agreements between manufacturers and local service providers are the factors promoting the growth of the global gait trainer market. Manufacturers of gait trainer devices and exoskeletons are focusing on government contracts and agreements with other medical device companies, in order to manufacture cost-effective products, especially for rehabilitation.

According to the report published by Future Market Insights (FMI), the global gait trainer market is expected to witness a CAGR of 4.9% from 2022 to 2028. In 2017, the market was worth US$ 271.5 Mn and is projected to rise to a valuation of US$ 456.3 Mn by the end of 2028.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-2213

Technological Advancements to Pave Way for Market Progression

In the last couple of years, various types of gait trainers to support ambulation practices have been developed, the treadmill and over ground systems are the ones gaining popularity. Advanced gait trainer systems are predominantly designed to minimize stress–strain shielding with adjustability in height, and increase the range of motion with high efficiency. As indicated by the expert analyst, New FDA-cleared EksoGT exoskeleton comes with a controller, inbuilt software coupled with smart assist pre-gait and freegait quick fit technology. Ekso pulse comes with a cloud-based technology, analytics, wireless transmission and cloud storage.

Competitive Pricing to Obstruct Growth Tract

The price elasticity of the gait trainer market has grown extensively owing to the significant role played by the government and managed care groups. HME dealers purchase gait trainer products based primarily on the price, so that they can be assured of being reimbursed. Thereby, manufacturers must fiercely compete on price in order to win large dealer contracts and purchases. The rising Asian imports of gait trainer are bound to send the prices to a certain low. With increasing number of participants, the prices will continue to decline.

Global Neurological Biomarkers Market: Snapshot

The neurological biomarkers are specific to the detection or analysis of molecular mechanism taking place in a person’s neurological disorder. Though the market’s scope is restricted to just the neurological segment of a human body, it holds a huge market share in the coming years. The growth is primarily driven by the increase of neurological disorders. There is a huge increase in the rate of population suffering from disorders like Alzheimer, Parkinson, Schizophrenia, Depression and Multiple Sclerosis.  The prevalence of such diseases has also triggered the drug development practices. Many researches are solely dedicated to development of various drugs in the market which are based on the results of biomarkers. Thus, the global neurological biomarkers market is expected to proliferate in the coming years. The market includes highest application of neurological biomarkers for Alzheimer, which is expected to hold the highest market share of over US$ 2,100 Mn in the global neurological biomarkers market. However, new application areas like Schizophrenia and Spinal Muscular Atrophy are expected to witness more attractiveness in the global market, as both the segments are expected to lead with a growth at high rate.

The report also reveals the growth to be seen majorly in Asia Pacific during the forecast period. The region is expected to gain attractiveness in the coming years, as the neurological biomarkers market finds larger area of application and grow at a CAGR of 6.1% during the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6626

Global Neurological Biomarkers Market: Upcoming Opportunities and Trends

Increasing prevalence of neurodegenerative disorders is expected to bolster the demand of neurological biomarkers in the global market. The growth is expected to introduce new trends in the market and help businesses capitalize on the opportunities coming their way. One of such trends is ELISA, which is a high sensitive method for detecting proteins in complex matrices such as urine, serum, plasma and saliva. It is considered as the best available method for quantification of proteins, and is also expected to gain traction in the coming years.  The major players that are behind introduction of such trends in the market and are also ruling the global neurological biomarkers market are Quanterix Corporation, Qiagen N.V., Thermo Fisher Scientific Inc. ADx Neurosciences NV, Merck KGaA., Acobiom, Banyan Biomarkers, Olink AB INC., Bio-Rad Laboratories, EuroImmun AG (Sub. PerkinElmer) etc.  There are many more trends in the market like mass spectroscopy and integrative biology. The coming years will project clear picture of the trend that will stand out and lead as a significant driver of global neurological biomarkers market.

Key Takeaways – Laparoscopic Devices Market Study

• Steady demand growth is observed for bariatric surgery, in line with the expanding obese population coupled with wide-scale adoption rate of minimally invasive techniques. Sales of laparoscopic devices for bariatric surgery will surpassing that for colorectal surgery towards the end of projection period.
• Sales of laparoscopic devices will be higher in North American countries. The availability of skilled surgeons and several advantages of minimally invasive surgery over open surgery are few factors driving the market of laparoscopy devices.
• The key players in the laparoscopic devices market are focusing on technologically advanced surgical systems with improved dexterity, ergonomics, and visual enhancements that provide advantages to surgeons and minimize the risk for patients while undergoing laparoscopic procedures.
• Increasing consumer base along with modern amenities in the healthcare sector is expected to drive sales of laparoscopic devices in developing regions.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-497

Rising private and foreign investments in the laparoscopic devices market and adoption of subscription commerce marketing model by market players are anticipated to shape the overall laparoscopic devices market.

Growing Popularity of Single-incision Laparoscopic Surgery

Single-site incisional surgery is being widely used in laparoscopic procedures and is replacing traditional method of laparoscopic procedures, in which four to five small incisions were made as the entry point for laparoscopic instruments. Some of the key benefits of single-site incision laparoscopic procedure over traditional procedure are low chances of infections, better cosmetic results, quick recovery and less post-operative pain.

According to Journal of the Society of Laparoendoscopic Surgeons (JSLS), women who undergo single-site incision laparoscopic surgery tend to report lesser post-operative pain compared to traditional method laparoscopic surgery. Growing demand for single-incision laparoscopic surgeries would thus drive the growth of laparoscopic devices market.

Adoption of Subscription Commerce Marketing Model

Companies are adopting various marketing model schemes such as subscription commerce to boost the sale of laparoscopic devices. Under this scheme, companies provide medical devices such as laparoscopy devices on pay-per-use basis. Thus, various end use segments can have access to these devices which might otherwise be prohibitively expensive, which in turn is helping manufacturers to expand their market share for laparoscopic devices, globally.

Due to intense competition, manufacturers of laparoscopic devices use innovative pricing strategies to remain at the forefront. Expanding access of laparoscopic devices by educating healthcare professionals through various conferences and training is enabling companies manufacturing these devices to enhance the adoption and equipping healthcare facilities with the necessary tools to provide optimal care to patients.

Interested in More About Report Inclusions?

Laparoscopic Devices Market, a new study from Future Market Insights, opines on the evolution of the laparoscopic devices market from 2014 – 2018 and presents demand projections from 2019 – 2029 on the basis of product type (direct energy system devices, trocars/access device, internal closure devices, laparoscopes, hand access instruments, insufflation devices, and robotic assisted surgical system), therapeutic application (bariatric surgery, colorectal surgery, general surgery,  gynecological surgery and urological surgery), and end user (hospitals, ambulatory surgical centers, and clinics) across seven major regions.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/497

Nucleic Acid Testing Market: Overview

Nucleic acid testing is helpful in the detection of the nucleic acids such as viral DNAs or RNAs in specimen samples of the patients. The technique is helpful in providing special assistance to doctors as well as patients. The healthcare industry needs advanced technique to cope with the increasing severity of health related issues that the population is more prone to. Increasing chronic disease incidences due to changing lifestyle have resulted in escalating demand for diagnostic procedures worldwide. Nucleic acid testing kits and consumables are the key products in the in-vitro diagnostic industry, as they have been proven to deliver promising results during critical diagnosis in various applications.

Emerging countries in the Asia Pacific region, such as China and India, are the hotspots for investments because of higher growth rate of diagnosis, treatment and research activities. Future Market Insights expects developing regional markets to experience higher demand for nucleic acid testing over the assessment period. According to the report, North America is expected to hold a market value of over US$ 1,600 Mn by the end of 2027 but APAC is expected to create more incremental opportunities and will reportedly witness a CAGR of 8.6% during the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1106

Nucleic Acid Testing Market: Trends

Looking at the recent demands for nucleic acid testing, key manufacturers are now focusing on introducing new custom product offerings for specific needs. Due to the research community’s ever evolving needs, the demand for specialised tools and reagents have grown to the point where most vendors who are currently offering these products cannot depend solely on sales of catalog products. Customised products are likely to trend in near future, creating attractive growth opportunities for emerging businesses.

The rise in demand has also encouraged many companies to look for expansion of their businesses. Various companies are emphasizing on expansion activities by setting-up their plants and regional offices in developing regions, including APAC and MEA. The competitive scenario of the market is consolidated, and a majority players prefer to involve in sales and service agreements, collaborations, R&D, new product launches, joint ventures, partnerships, patent transfers, and mergers and acquisitions.